La Jolla Pharmaceutical Company Receives Positive Opinion from European Orphan Committee for LJPC-401
September 11, 2015 at 08:00 AM EDT
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the "Company" or "La Jolla"), a leader in the development of innovative therapies ...